A 2019 study demonstrated that IP4 plays a critical role in redox homeostasis upon cisplatin exposure by reducing cisplatin-induced ROS through inhibition of a ROS-generating enzyme, NADPH oxidase 4 (NOX4), which promotes cisplatin-resistant tumor growth (Pan et al., 2019). This evidence concerns the gene NOX4 and neoplasm.